0,702  0,006  Antineoplastic (cervical cancer)
0,623  0,005  Antineoplastic (carcinoma)
0,600  0,035  Antineoplastic (breast cancer)
0,546  0,018  Spasmolytic
0,557  0,043  Caspase 9 stimulant
0,552  0,060  Apoptosis agonist
0,533  0,074  Antiinflammatory
0,493  0,043  Antibacterial
0,435  0,026  Antineoplastic (non-small cell lung cancer)
0,413  0,026  DNA damaging
0,423  0,037  Hepatic disorders treatment
0,417  0,036  Antimycobacterial
0,412  0,034  CTGF expression inhibitor
0,428  0,055  Antileukemic
0,406  0,034  UGT1A9 substrate
0,396  0,039  Cardioprotectant
0,388  0,031  Mutagenic
0,380  0,036  Hypoxia-inducible factor 1 alpha inhibitor
0,383  0,048  Antineoplastic (ovarian cancer)
0,368  0,035  Proliferative diseases treatment
0,343  0,014  Topoisomerase II inhibitor
0,373  0,044  Lipoxygenase inhibitor
0,370  0,042  Antineoplastic (glioma)
0,367  0,042  Antituberculosic
0,360  0,034  Antineoplastic (glioblastoma multiforme)
0,379  0,057  Prostate cancer treatment
0,362  0,041  Cytotoxic
0,336  0,016  Pneumotoxic
0,375  0,059  Antineoplastic (colorectal cancer)
0,362  0,057  Antifungal
0,356  0,052  NOS3 expression inhibitor
0,355  0,052  Antineoplastic (melanoma)
0,361  0,058  Antineoplastic (colon cancer)
0,342  0,049  Antioxidant
0,321  0,029  Sedative
0,304  0,012  NADPH oxidase inhibitor
0,332  0,045  Cytostatic
0,296  0,013  Alkylator
0,318  0,037  Nitric oxide antagonist
0,350  0,078  CYP3A4 substrate
0,320  0,056  Antineoplastic (small cell lung cancer)
0,326  0,068  AR expression inhibitor
0,355  0,097  Histamine release inhibitor
0,323  0,066  Respiratory analeptic
0,301  0,044  Antineoplastic (bladder cancer)
0,334  0,087  CYP2C9 substrate
0,304  0,061  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,279  0,037  UGT1A1 substrate
0,297  0,058  Chemoprotective
0,261  0,023  Monophenol monooxygenase inhibitor
0,287  0,055  Free radical scavenger
0,249  0,018  Antifungal enhancer
0,287  0,060  NOS2 expression inhibitor
0,282  0,056  Antineoplastic (lymphoma)
0,262  0,037  UGT2B7 substrate
0,299  0,076  Analeptic
0,251  0,030  UGT1A3 substrate
0,299  0,079  Caspase 3 stimulant
0,318  0,098  Ulceration
0,308  0,090  Transcription factor NF kappa B inhibitor
0,254  0,040  UGT1A4 substrate
0,230  0,020  Topoisomerase I inhibitor
0,274  0,065  Antineoplastic (renal cancer)
0,259  0,050  Chemopreventive
0,279  0,072  Aldehyde oxidase inhibitor
0,240  0,041  Antimutagenic
0,203  0,005  Cathepsin L2 inhibitor
0,221  0,022  DNA polymerase I inhibitor
0,240  0,056  RNA-directed DNA polymerase inhibitor
0,198  0,015  Topoisomerase II alpha inhibitor
0,252  0,071  Antineoplastic (liver cancer)
0,276  0,099  Bone diseases treatment
0,264  0,088  CYP1A2 substrate
0,192  0,019  MAP3K9 inhibitor
0,258  0,092  Antihypoxic
0,202  0,038  UGT2B9 substrate
0,273  0,112  Antineoplastic (lung cancer)
0,218  0,061  UDP-glucuronosyltransferase substrate
0,185  0,030  DNA intercalator
0,190  0,039  Skin whitener
0,210  0,059  Hepatoprotectant
0,233  0,085  Antidiabetic symptomatic
0,227  0,086  DNA synthesis inhibitor
0,163  0,024  Antineoplastic alkaloid
0,190  0,052  Antirickettsial
0,184  0,048  Protein kinase stimulant
0,219  0,083  Antihypotensive
0,233  0,103  UGT2B4 substrate
0,183  0,055  Antiviral (Herpes)
0,176  0,050  Antineoplastic (squamous cell carcinoma)
0,160  0,039  Antihemorrhagic
0,170  0,049  Mannose-6-phosphate isomerase inhibitor
0,270  0,150  TNF expression inhibitor
0,262  0,144  GABA C receptor rho-3 antagonist
0,216  0,103  Antineoplastic (sarcoma)
0,167  0,057  Lipid peroxidase inhibitor
0,239  0,130  Antineoplastic (osteosarcoma)
0,203  0,095  Peptidyltransferase inhibitor
0,198  0,090  VCAM1 expression inhibitor
0,180  0,080  P-glycoprotein inhibitor
0,160  0,060  Genotoxic
0,130  0,034  Creatine kinase inhibitor
0,122  0,028  NAD(P)H dehydrogenase (quinone) inhibitor
0,158  0,064  UGT2B15 substrate
0,244  0,152  Immunosuppressant
0,275  0,185  Cyclophilin D inhibitor
0,275  0,185  Antidiabetic
0,157  0,067  Aldose reductase substrate
0,128  0,046  5-Lipoxygenase inhibitor
0,115  0,034  SULT1E1 substrate
0,186  0,108  UGT1A6 substrate
0,195  0,117  Hypoglycemic
0,184  0,112  Antineoplastic (lymphocytic leukemia)
0,141  0,069  Ca2+-transporting ATPase inhibitor
0,168  0,096  Amyloid beta aggregation inhibitor
0,224  0,153  Apoptosis antagonist
0,271  0,200  5 Hydroxytryptamine release inhibitor
0,208  0,138  Antineoplastic (multiple myeloma)
0,205  0,138  CYP2D6 substrate
0,161  0,095  Platelet adhesion inhibitor
0,129  0,063  Antineoplastic (uterine cancer)
0,137  0,071  Psychosexual dysfunction treatment
0,107  0,043  Antineoplastic antibiotic
0,106  0,042  Androgen antagonist
0,121  0,057  Cystathionine beta-synthase inhibitor
0,116  0,053  Electron transport complex I inhibitor
0,096  0,035  Telomerase inhibitor
0,178  0,120  Antihypercholesterolemic
0,069  0,015  Pregnane X receptor antagonist
0,253  0,202  Calcium channel L-type activator
0,075  0,026  Protein kinase C eta inhibitor
0,111  0,063  Mucolytic
0,170  0,123  Antiamyloidogenic
0,120  0,078  Acetylcholinesterase inhibitor
0,049  0,010  Melatonin 1 agonist
0,130  0,092  Antiprotozoal (Coccidial)
0,165  0,127  VEGF expression inhibitor
0,047  0,011  Melatonin 2 agonist
0,175  0,140  MAP-kinase-activated kinase 5 inhibitor
0,187  0,153  Radiosensitizer
0,164  0,130  Antineoplastic enhancer
0,148  0,116  Succinate dehydrogenase inhibitor
0,145  0,113  Lipocortins synthesis antagonist
0,097  0,065  Carbonic anhydrase III inhibitor
0,100  0,068  Expectorant
0,107  0,077  Photosensitizer
0,069  0,044  Andropause treatment
0,044  0,020  Retinoic acid alpha receptor agonist
0,037  0,015  Estrogen-related receptor beta antagonist
0,095  0,073  Estrogen receptor beta antagonist
0,100  0,079  SULT1A1 substrate
0,056  0,036  Postmenopausal disorders treatment
0,149  0,129  Antihypertriglyceridemic
0,140  0,122  UGT2B10 substrate
0,105  0,087  Estrogen antagonist
0,036  0,019  Melatonin agonist
0,074  0,059  Antitreponemal
0,159  0,145  Antipyretic
0,049  0,036  Estrogen agonist
0,062  0,049  Leukotriene antagonist
0,034  0,024  Estrogen receptor alpha agonist
0,088  0,079  Glutathione S-transferase substrate
0,042  0,033  Dopamine D2 agonist
0,099  0,089  Cholesterol synthesis inhibitor
0,034  0,025  Retinoid X alpha receptor agonist
0,125  0,118  Carcinogenic
0,061  0,054  5 Hydroxytryptamine agonist
0,084  0,077  Restless leg syndrome treatment
0,099  0,093  Antiseptic
0,055  0,049  Androgen agonist
0,137  0,131  Angiogenesis stimulant
0,104  0,100  Contraceptive
0,048  0,045  Maillard reaction inhibitor
0,107  0,105  DNA repair enzyme inhibitor
0,089  0,088  UGT2B1 substrate

